SEC Form 4 · accession 0001493152-18-006360
Cocrystal Pharma, Inc. · COCP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond F Schinazi
Director · 10% Owner
Period of report
May 3, 2018
Accepted (ET)
May 7, 2018 · 6:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412486
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 3, 2018 | A | 420,737 | $1.90 | A | 722,226 | I | By LP |
| Common Stock | holding | — | — | — | 929,525 | I | By LLC | |
| Common Stock | holding | — | — | — | 9,240,928 | D |
Table II — derivative securities
No Table II lines on this filing.